Skip to main content
. Author manuscript; available in PMC: 2016 Dec 1.
Published in final edited form as: Cancer Prev Res (Phila). 2015 Oct 15;8(12):1131–1137. doi: 10.1158/1940-6207.CAPR-14-0274-T

Figure 1. Study Schema.

Figure 1

Subjects were randomized to a 6-month, twice daily (BID) oral treatment of either placebo or Poly E (200 mg, 400 mg, 600 mg dose cohorts). Endoscopic evaluation, including multiple biopsies, was performed at baseline and after treatment.